Population Health Management for KPNC Members With Newly Diagnosed Diabetes: A Randomized Trial of a Proactive and Augmented Initial Care Strategy

Enrolling by invitation · Not applicable

Conditions studied: Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes (T2D)

In brief

This study is a 2-arm randomized trial of Augmented Initial Type 2 Diabetes (T2D) Care vs. Usual Initial T2D Care among adults (18-74 years) with newly diagnosed T2D who have risk factors (defined by age and diagnosis HbA1c value) for suboptimal early glycemic control. Augmented Initial T2D Care comprises the elements of usual care augmented by more proactive and intensive outreach from the diabetes care team. The study team will use electronic health record (EHR) data to assess between-arm differences in diabetes-related outcomes at 6- and 12 months.

Key facts

Study ID

NCT06906653

Run by

Kaiser Permanente

People needed

204

Starts

2025-04-01

Expected to finish

2027-06-01

Last updated by the study team

2025-04-02

Who can join

Age: 18 and older, up to 74. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-74 years
• Newly diagnosed with type 2 diabetes
• Kaiser Permanente Northern California member receiving care in a participating service area
• If age ≤45 years, then HbA1c>8%
• If age<45 years, then HbA1c>10%

You may not qualify if…

• Individuals who are pregnant
• Individuals with likely type 1 diabetes (T1D)

Where it is running

• Kaiser Permanente Division of Research — Pleasanton, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.